Publication

1- Innovative Medicines & Medical Practice During COVID At Glsbor Region

  • Medical practice during COVID -19 pandemic faced many challenges one of the major challenges is adaptation of treatment protocols for achieving following objectives.
  • Managing system capacity, enhancement of patient’s outcomes (quality of life – economic value – clinical effectiveness). And utilizing the resources during this hard time.
  • Previous objectives raised many questions about nature of treatment protocols and policies should be implemented during (COVID -19) pandemic and how innovative medicines can achieve the previous objectives. At MENA countries (Algeria, Morocco, Egypt, Lebanon, KSA, UAE and Turkey) at four specialties (Oncology, cardio metabolic, ophthalmology, rare diseases)

2- COVID-19 And Oncology Practice At Glsbor Regions. Analysis & Recommendations

  • Pandemicity of COVID- 19 was not expected from any health systems it did not matter if those systems were strong or weak that Pandemicity developed various responses from different specialties. The objectives of this research is analyze impact of COVID -19 on oncology practice at GLSBOR countries (Algeria, Morocco, Egypt, Lebanon, KSA, UAE and Turkey) to find out recommendation

3- Health Systems Response To Covid -19 Pandemicity At Low & Middle Income Countries

  •  Pandemicity of Covid- 19 was not expected from any health systems it did not matter if those systems were strong or weak that Pandemicity developed various responses and leaded to questions asked from all health care professionals like

  • 1. Lessons learned from Covid- 19 to health systems?
  • 2. Analysis of health systems response to Covid Pandemicity?
  • 2. Future of Health systems after Covid- 19.
  • The objective of that research is trying to answer about the previous questions trying to find recommendations, solutions for the MENA regions countries through policy analysis for MENA health systems at the following aspects
  • 1. Health systems response capacity to pandemicity
  • 2. Time for Response.
  • 3. Surveillance polices response.
  • 4. Infection control policies response

4- Innovative Medicines & Oncology Practice During Covid At GLSBOR Regions Policy AnalysisGLSBOR

  • Oncology practice during COVID -19 pandemic faced many challenges one of the major challenges is adaptation of treatment protocols for achieving following objectives. Managing system capacity, Enhancement of patient’s outcomes (quality of life –economic value – clinical effectiveness). And utilizing the resources during this hard time. Previous objectives raised many questions about nature of treatment protocols and policies should be implemented during (COVID -19) Pandemic and how innovative medicines can achieve the previous objectives. At MENA countries (Algeria, Morocco, Egypt, Lebanon, KSA, UAE and Turkey)

5-COVID -19 And Cardio Metabolic Practice At GLSBOR Regions. Policy Analysis & Recommendations

Pandemicity of COVID- 19 was not expected from any health systems it did not matter if those systems were strong or weak that Pandemicity developed various responses from different specialties. The objectives of this research is analyze impact of COVID -19 on Cardio metabolic practice at MENA countries (Algeria, Morocco, Egypt, Lebanon, KSA, UAE and Turkey) to find out recommendations

6- Policy Analysis Of Accessibility For Rare And Ultra-Rare Diseases At GLSBOR Region

  • Rare and ultra-rare diseases treatments have their differences form regular treatments for regular diseases for the following

            * Nature of definitions for that diseases

            * Treatment protocol.

            * Targeted paints.

            * Technology assessment for that treatments

            * Funding and financing for reimbursement strategies.

  • The objectives of the research are to analyze and defines factors affecting accessibility for rare and ultra-rare diseases at MENA region.